Literature DB >> 19081784

Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.

Kate B Carey1, Luba Leontieva, Jacqueline Dimmock, Stephen A Maisto, Steven L Batki.   

Abstract

The co-occurrence of schizophrenia and alcohol use disorders often leads to poor treatment retention and adherence. Both empirical research and statements of best practices suggest that interventions including motivational interviewing principles can enhance treatment engagement and improve outcomes. This article describes a set of exercises used within a motivational enhancement protocol for outpatients with schizophrenia-spectrum and alcohol use disorders. We describe how each exercise was tailored to the target population, and how it is designed to enhance motivation to change and treatment engagement. Examples from clinical transcripts are used to demonstrate how motivational interviewing is adapted to the cognitive, social, and environmental circumstances associated with schizophrenia.

Entities:  

Year:  2007        PMID: 19081784      PMCID: PMC2600522          DOI: 10.1111/j.1468-2850.2007.00061.x

Source DB:  PubMed          Journal:  Clin Psychol (New York)        ISSN: 0969-5893


  34 in total

Review 1.  Subject reactivity effects and alcohol treatment outcome research.

Authors:  P R Clifford; S A Maisto
Journal:  J Stud Alcohol       Date:  2000-11

Review 2.  Feedback interventions for college alcohol misuse: what, why and for whom?

Authors:  Scott T Walters; Clayton Neighbors
Journal:  Addict Behav       Date:  2005-01-20       Impact factor: 3.913

3.  Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach.

Authors:  K B Carey
Journal:  Community Ment Health J       Date:  1996-06

4.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

Review 5.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

6.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

Review 7.  Motivation for treatment: a review with special emphasis on alcoholism.

Authors:  William R Miller
Journal:  Psychol Bull       Date:  1985-07       Impact factor: 17.737

8.  Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention.

Authors:  K B Carey; D M Purnine; S A Maisto; M P Carey
Journal:  Behav Modif       Date:  2001-07

9.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

10.  Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study.

Authors:  D C Daley; I M Salloum; A Zuckoff; L Kirisci; M E Thase
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

View more
  1 in total

1.  Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia.

Authors:  Luba Leontieva; Jacqueline Dimmock; Michelle Cavallerano; Sara DeRycke; Zsuzsa Meszaros; Kate Carey; Robert Ploutz-Snyder; Steven L Batki
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.